What is the ticker symbol for Amarin?

Amarin trades under the ticker AMRN on NASDAQ.

What sector does Amarin operate in?

Amarin is classified in the Healthcare sector (Drug Manufacturers - General industry).

How can PortView help analyze AMRN in a portfolio?

PortView shows AMRN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Amarin (AMRN) Stock Analysis

NASDAQHealthcareDrug Manufacturers - General

$12.67+6.05%

1-year price historyRange $11.32 – $18.94

52-week range$12.67

$11.25$18.50

Track AMRN in your portfolio for free · Portfolio tracker

What Amarin does

Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several international regions, including the United States, Germany, Canada, Lebanon, and the United Arab Emirates. The company's flagship product is VASCEPA, an omega-3 fatty acid formulation available by prescription only. This medication acts as an adjunctive therapy to diet, designed to decrease elevated triglyceride levels in adult patients suffering from severe hypertriglyceridemia. Amarin primarily distributes its offerings through wholesale channels and specialized pharmacy providers. Furthermore, the company has entered into a collaboration with Mochida Pharmaceutical Co., Ltd. to advance the development and market introduction of drug products and new indications derived from Vascepa's active pharmaceutical ingredient, which encompasses omega-3 acid and eicosapentaenoic acid. Established in 1989 as Ethical Holdings plc, the organization rebranded to Amarin Corporation plc in 1999. Its corporate headquarters are located in Dublin, Ireland.

Key metrics

Market cap

$262.11M

P/E (TTM)

-126.73

EPS (TTM)

$-0.10

Beta

0.77

Dividend yield

0.00%

Revenue / share

$8.45

50-day avg

$13.07

200-day avg

$14.35

52-week high

$18.50

52-week low

$11.25

CEO

Aaron D. Berg

ETFs linked to AMRN

Broad-market and Healthcare sector ETFs an investor holding Amarin is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how AMRN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AMRN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Amarin?: Amarin trades under the ticker AMRN on NASDAQ.
Which exchange is AMRN listed on?: AMRN is listed on NASDAQ.
What sector does Amarin operate in?: Amarin is classified in the Healthcare sector (Drug Manufacturers - General industry).
How can PortView help analyze AMRN in a portfolio?: PortView shows AMRN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.